Stay updated on ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Sign up to get notified when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.

Latest updates to the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.6.5, was added to the study's revision history. This indicates an updated version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.6.4 was added to the study's history, and the previous revision v3.6.3 was removed, indicating an update to the study record version.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry v3.6.3 was added to the history, and the v3.6.2 entry was removed. This updates the log of revisions for the record.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.2 was added to the Record History, and the previous revision v3.6.0 was removed, updating the version history of the study record.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record view removes several standard sections and navigation items (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, and Study Status) as well as related help text. This change reduces direct access to key trial data in the version history interface.SummaryDifference9%

- Check58 days agoChange DetectedThe record history shows the study is no longer recruiting participants. It also records a new revision, version 3.6.0, replacing the previous 3.5.5 revision.SummaryDifference0.4%

Stay in the know with updates to ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.